Proceedings of the International scientific and practical conference ―Modern Science: Challenges and Perspectives‖ (February 9-11, 2026) / Publisher website: www.naukainfo.com. - London, United Kingdom, 2026. - 121 p.

113 8. Weniger, M. A., Tiacci, E., Schneider, S., et al. (2018). Human CD30+ B cells represent a unique subset related to Hodgkin lymphoma cells. The Journal of Clinical Investigation, 128(7). https://doi.org/10.1172/JCI95993 9. Kartan, S., Johnson, W. T., et al. (2019). The spectrum of CD30+ T-cell lymphoproliferative disorders in the skin. Chinese Clinical Oncology. https://doi.org/10.21037/cco.2018.12.03 10. Shi, J.-H., & Sun, S.-C. (2018). Tumor necrosis factor receptor-associated factor regulation of nuclear factor κB and mitogen-activated protein kinase pathways. Frontiers in Immunology, 9, 1849. https://doi.org/10.3389/fimmu.2018.01849 11. Vrzalikova, K., Pugh, M., Mundo, L., & Murray, P. (2021). The contribution of EBV to the pathogenesis of classical Hodgkin lymphoma. Annals of Lymphoma. https://doi.org/10.21037/aol-21-8 12. Andersen, O., Ernberg, I., & Hedström, A. K. (2023). Treatment options for Epstein–Barr virus-related disorders of the central nervous system. Infection and Drug Resistance, 16. https://doi.org/10.2147/IDR.S375624.